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ABSTRACT
Group B streptococci (GBS) are an important cause of neonatal sepsis and meningitis. New rapid,
sensitive and speciﬁc methods for detection of GBS in pregnant women are needed in order to provide
timely treatment of neonates. The sensitivity, speciﬁcity and cost of a LightCycler PCR method was
compared with selective culture for the detection of GBS from 400 vaginal swabs. In addition, two DNA
extraction methods (simple boiling and automated DNA extraction by Roche MagNA Pure LC) were
compared for a subgroup of 100 clinical samples. The sensitivity of the LightCycler PCR assay for the
detection of GBS from vaginal swabs was signiﬁcantly higher than that of culture. There were no
culture-positive, LightCycler PCR-negative cases. The efﬁciencies of the two DNA extraction procedures
were not signiﬁcantly different. The detection of GBS from vaginal swabs by the molecular method
(including simple boiling extraction) required the same hands-on time, but the procedure was
completed in 1.5 h, compared with c. 48 h for the culture-based approach. Disadvantages of the
molecular method are the increased costs (45%) and the absence of antibiogram data. The LightCycler
PCR is a promising tool for sensitive, speciﬁc and rapid detection of GBS directly from clinical
specimens of pregnant women.
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INTRODUCTION
Group B streptococci (GBS; Streptococcus agalac-
tiae) are a leading cause of sepsis, meningitis
and death among newborn infants in developed
countries. Approximately 10–40% of pregnant
women are colonised by GBS, in either the
vagina or the rectum, and 40–70% of these
women transfer GBS to the neonate [1]. Neona-
tal infection usually results from vertical trans-
mission during delivery, or acquisition in utero
just before labour. Of the colonised neonates,
1–3% develop disease, almost always in the
form of early-onset infection within 24 h of birth
[2]. Early-onset disease in the neonate is deﬁned
as the clinical presentation of pathology, mainly
sepsis and meningitis, within the ﬁrst week of
life [1]. Neonatal infection can be prevented in
most cases by providing intrapartum antimicro-
bial prophylaxis to the colonised mother [1,3].
Hence, determination of colonisation by GBS at
the time of labour is essential.
Screening all pregnant women for carriage of
GBS between week 35 andweek 37 of pregnancy is
a recommended approach for avoiding the trans-
mission of GBS from mothers to neonates [4]. The
current standard methods for detection of GBS
consist of selective broth cultures of combined
vaginal and anal specimens. Although these meth-
ods are sensitive and speciﬁc, they are time-
consuming, requiring 48–72 h, and also require
the presence of viable organisms [1]. Many simple
and rapid tests for GBS have been developed, but
these are not useful for direct detection because
they are neither sensitive nor speciﬁc enough to
substitute for bacterial culture [5,6]; thus, only
women with heavy colonisation can be identiﬁed
readily with such methods. Hence, new rapid,
sensitive and speciﬁc methods for direct detection
of GBS from clinical specimens in pregnantwomen
are needed for timely treatment of neonates.
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Several PCR-based assays for the detection of
GBS have been developed, but these require
complicated procedures not applicable readily
to clinical laboratories [7]. However, the devel-
opment of real-time PCR (rt-PCR) and ﬂuores-
cence-labelling technologies has provided new
platforms for bacterial detection and identiﬁca-
tion. PCR assays speciﬁc for GBS are promising
tools for rapid, sensitive and speciﬁc detection
directly from clinical specimens. Ke et al. [8]
developed an rt-PCR method based on ampliﬁ-
cation of a cfb gene fragment that is present in
virtually every strain of GBS [9]. Bergeron et al.
[10] showed that this rt-PCR was speciﬁc but,
surprisingly, only of equivalent sensitivity to the
conventional bacterial culture test. Details of a
qualitative test based on ampliﬁcation of the
same cfb gene fragment have recently been
published [11].
Quantiﬁcation, in addition to identiﬁcation of
the pathogen, may provide important information
about the potential evolution of an infection, or
the course of the disease, by quantifying the
amount of genomic DNA of a speciﬁc bacterium
in a patient sample [12].
In the present study, the sensitivity, speciﬁc-
ity and cost of a LightCycler PCR method were
compared with those of selective culture for
detection of GBS from 400 clinical samples. In
addition, two DNA extraction methods (simple
boiling and automated DNA extraction) were
compared for a subgroup of 100 clinical sam-
ples.
MATERIALS AND METHODS
Collection of specimens and preliminary treatment
Between August and December 2003, 400 vaginal swabs were
obtained from pregnant women at 33–37 weeks of gestation.
All specimens were collected and transported to the Instituto
Cantonale di Microbiologia (Bellinzona, Switzerland), using
the Amies Clear Transystem (Verridial, Blonay, Switzerland).
All swabs were ﬁrst inoculated for standard culture, and then
dipped into 500 lL of sterile distilled water for DNA extrac-
tion and LightCycler PCR assay.
Enrichment and selective culture
All 400 vaginal swabs were cultured in 5 mL of LIM broth
(Todd–Hewitt broth with colistin and nalidixic acid; Chemie
Brunschwig, Basel, Switzerland) and incubated overnight at
room temperature. Columbia CNA plates (Columbia Agar
Base, deﬁbrinated sheep blood 5% v ⁄v, selective supplement
for the isolation of streptococci; Oxoid, Basel, Switzerland)
were then inoculated with 50 lL of broth [4]. The plates were
incubated at 37C in CO2 5% v ⁄v for 24–48 h. Species
identiﬁcation of b-haemolytic colonies was performed by
agglutination with a streptococcal grouping kit (Streptex;
Sodiag SA, Losone, Switzerland).
DNA extraction
DNA was extracted from all 400 vaginal swabs with the
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche
Diagnostics, Rotkreuz, Switzerland), used according to the
manufacturer’s instructions, and in addition, from a subgroup
of 100 randomly selected clinical samples, by simple boiling of
250 lL of the 500-lL suspension for 10 min. Finally, the DNA
preparations were stored at 4C.
LightCycler PCR assay
The LightCycler (v. 3.5; Roche Diagnostics) was used to
perform rt-PCR. Primers and probes were as described
previously [8] and were synthesised by TIB MOLBIOL (Berlin,
Germany). Brieﬂy, primers StrepB1 (5¢-TTTCACCAGCTG-
TATTAGAAGTA-3¢) and StrepB2 (5¢-GTTCCCTGAACATT-
ATCTTTGAT-3¢) amplify a 153-bp fragment of the cfb gene.
The probes used were pStB-ﬂu (5¢-AAGCCCAGCAAA-
TGGCTCAAA–FL-3¢) and pStB-lcr (5¢-LC Red640-GCTTGAT-
CAACATAGCATTCAGTTGA–PH-3¢). Each 20-lL reaction
volume contained 2 lL of LightCycler DNA Master Hybrid-
ization Probes mix (Roche Diagnostics), 0.4 lM each primer,
0.2 lM each probe, 0.1 U of uracil-DNA glycosylase (UNG;
Roche Diagnostics), 3.5 mM MgCl2 and 5 lL of DNA extract.
One positive and several negative controls were included in
each run. Strict precautions to prevent carryover of ampliﬁed
DNA were used.
Thermocycling conditions were optimised to one cycle at
95C for 10 min, followed by 55 cycles of 10 s at 95C, 14 s at
57C and 5 s at 72C, with a temperature transition rate of
20C ⁄ s. The ﬂuorescence was measured at the end of each
extension step. The melting curve program comprised 95C for
10 s (20C ⁄ s), 54C for 15 s (20C ⁄ s), and 78C for 10 s
(0.2C ⁄ s), with continuous ﬂuorescence acquisition.
Samples with discordant results (positive by LightCycler
and negative by standard culture) were investigated further by
DNA sequence analysis of the ampliﬁcation product.
DNA sequencing
PCR products were puriﬁed using the Amicon Microcon Kit
(Millipore, Volketswil, Switzerland), eluted in 20 lL of AE
buffer and stored at 4C. Cycle sequencing reactions were
performed in total volumes of 15 lL, using an ABI Prism
Big Dye Terminator Cycle Sequencing Kit (Perkin-Elmer
Applied Biosystems, Rotkreuz, Switzerland) on an ABI
Prism 310 Genetic Analyser (Perkin-Elmer Applied Bio-
systems), according to the manufacturer’s instructions. DNA
sequencing for GBS (cfb gene fragment of 153 bp) was
performed in both directions with primers StrepB1 and
StrepB2.
PCR speciﬁcity and sensitivity
The speciﬁcity of the rt-PCR assay was veriﬁed by testing
genomic DNA from bacterial species related phylogenetically
to GBS and from other species often present in the vaginal ﬂora
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(n = 89; Table 1). Clinical isolates of GBS (n = 40) were also
tested to further validate the GBS-speciﬁc rt-PCR. The
sensitivity of the method was determined as described below.
Cloning of the cfb amplicon and quantiﬁcation of genomes
of GBS
The 153-bp fragment of the cfbgenewas ampliﬁed fromgenomic
DNA of GBS with the use of primers StrepB1 and StrepB2. The
ampliconwas puriﬁed using the AmiconMicrocon Kit andwas
cloned using the TOPO TA cloning kit (Invitrogen, Basel,
Switzerland) according to the manufacturer’s instructions. The
recombinant plasmidwas isolated from transformed Escherichia
coli with a QIAprep spin miniprep kit (Qiagen, Basel, Switzer-
land). The puriﬁed plasmid was serially diluted and the DNA
concentration was determined using a PicoGreen dsDNA
quantitation kit (Molecular Probes; Juro Supply, Lucern,
Switzerland). Quantiﬁcation of genomes of GBS from clinical
samples was achieved using the standard curve generated by
serial dilutions of reference plasmid DNA.
Statistical analysis
The sensitivities of the LightCycler PCR assay and the culture
method were compared by McNemar’s chi-square test. The
Wilcoxon rank sum test was used for comparison of sensitivity
between the two DNA extraction methods.
RESULTS
Sensitivity and speciﬁcity of the real-time PCR
assay
All 40 clinical isolates of GBS, but none of the non-
group B streptococcal isolates, generated a clear
positive signal with the rt-PCR assay (Table 1).
The lower limit of the assay was found to be one
group B streptococcal genome copy ⁄PCR assay
(data not shown).
Validation of the real-time PCR assay
The standard culture method was used as base-
line in order to evaluate the effectiveness of the
rt-PCR method. In total, 400 vaginal swabs were
tested, of which 278 (69.5%) were negative by
culture and LightCycler PCR, 75 (18.8%) were
positive by both methods, and 47 (11.8%) were
positive only by PCR. There were no vaginal
swabs that were positive by culture only
(Table 2). Thus, the LightCycler PCR generated
signiﬁcantly (p < 0.001; McNemar’s chi-square
test) more positive results (30.5%) than did the
culture method (18.8%).
To exclude PCR false-positives, the amplicons
from the specimens with discrepant results (i.e.,
LightCycler PCR-positive and culture-negative)
(n = 47) were sequenced in both directions. Since
the analysed sequences generally differed from
each other by one or more nucleotides, carryover
contamination between samples could be exclu-
ded. Thus, use of the rt-PCR method resulted in
an increase of 62% in the number of GBS detected
compared with culture.
Quantitative data for 250 clinical samples,
selected randomly, were also generated. The
results suggested that rt-PCR was more sensitive
than the culture method. Thus, culture-positive
specimens contained 1.4-fold more DNA than
samples that were positive only by rt-PCR (data
not shown).
Comparison of two DNA extraction methods
DNA was extracted from 100 vaginal swabs by
both simple boiling and the MagNA Pure LC
method. All swabs positive by MagNA Pure were
also positive by boiling, even though comparison
of the median rt-PCR results indicated a trend to
higher sensitivity after extraction by MagNA Pure
(MagNA Pure, 7.7 · 101 copies of the cfb gene ⁄
5 lL; boiling, 3.2 · 102 copies ⁄ 5 lL; p 0.085,
Wilcoxon rank sum test).
Table 1. Bacterial strains (n = 89) used to test the specif-
icity of the PCR assay speciﬁc for group B streptococci
Genus Species (no. of strains)
Streptococcus S. pneumoniae (5)
S. pyogenes (6)
Group C streptococcus (2)
Group D streptococcus (4)
Group F streptococcus (5)
Group G streptococcus (4)
Non-haemolytic streptococci (2)
Enterococcus Enterococcus spp. (10)
Listeria L. monocytogenes (5)
Enterobacter Ent. aerogenes (3)
Ent. cloacae (4)
Escherichia E. coli (5)
Gardnerella G. vaginalis (1)
Haemophilus H. inﬂuenzae (5)
Klebsiella K. oxytoca (3)
K. pneumoniae (5)
Proteus P. mirabilis (5)
Pseudomonas Ps. aeruginosa (5)
Staphylococcus Staph. aureus (5)
Coagulase-negative staphylococci (5)
Table 2. Comparison of positive and negative results
between the real-time PCR assay and standard culture
for detection of group B streptococci
Standard culture
LightCycler PCR assay
Positive Negative
Positive 75 (18.75%) 0 (0%)
Negative 47 (11.75%) 278 (69.50%)
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DISCUSSION
The present study found that 122 (30.5%) of 400
women were colonised with GBS according to the
rt-PCR assay. This percentage is consistent with
other data obtained by similar molecular methods
[10,13], and suggests, in contrast to the results of
Bergeron et al. [10], that the LightCycler PCR
assay is more sensitive than the standard culture
method for detecting GBS from vaginal swabs.
Indeed, a 62% increase in the number of samples
positive for GBS was obtained by LightCycler
PCR (n = 122) compared with culture (n = 75),
and this was conﬁrmed by sequencing the ampl-
icons from the PCR-positive, culture-negative
samples. Previous prospective clinical studies
with various pathogens have consistently dem-
onstrated increases in sensitivity for assays based
on LightCycler PCR technology compared with
standard culture methods [14,15]. In addition, the
LightCycler technique provides same-day results,
thereby allowing timely and appropriate antimi-
crobial therapy, and thus lessening the risks of
undesirable sequelae.
Forty-seven (11.8%) of 400 vaginal samples
were positive only by rt-PCR and were conﬁrmed
by DNA sequencing. This difference may be
caused by the inability of culture to detect low
bacterial numbers (which appeared to be the case
in the present study), or by the presence of
antagonistic microorganisms, such as Candida
albicans [16]. Heavy colonisation with GBS corre-
lates with a higher risk of neonatal sepsis, while,
conversely, a low number of GBS is associated
with a decreased risk of neonatal disease [17]. The
rt-PCR also detects non-viable bacterial cells,
which could, in part, also explain the higher
detection rate by PCR.
As rt-PCR does not require viable organisms,
but detects DNA, inappropriate storage or trans-
port of specimens should not alter the efﬁciency
of the method. The ability of culture to identify
GBS declines quickly, or can be compromised, if
antibiotics or hygiene products (which often
contain antibacterial agents) are present locally
when sampling is performed [16]. The risk of
infection with GBS may be overlooked if culture is
the only method of evaluating the maternal group
B streptococcal colonisation status. However,
culture is still required when an antibiogram is
needed. Penicillin is the drug of choice for
prophylaxis and treatment of disease caused by
GBS, and to date, resistance to this agent has not
been reported among GBS. However, macrolides
are the recommended second-line agents, and the
ﬁrst alternative for mothers with a penicillin
allergy [18]. Several studies have reported
increasing resistance to macrolides among GBS
[3,18]. Thus, PCR cannot replace culture if sus-
ceptibility testing is required.
The efﬁciency of detection of GBS by Light-
Cycler PCR may be related both to the inherent
qualities of the rt-PCR assay and to the DNA
extraction technique used. Sample preparation is
one of the most important steps when performing
PCR. The present study demonstrated that the
analytical sensitivity of detection of GBS by
rt-PCR was similar after DNA extraction by either
the MagNA Pure LC Kit or simple boiling.
Qualitatively, no signiﬁcant discrepancies were
found. The time required for extraction of a
comparable number of specimens was greater
(1 h) for the MagNA Pure method than for boiling
(15 min), and compared with culture, the boiling
method was simple and provided sufﬁcient PCR
sensitivity.
Practical considerations, such as ﬂexibility,
workload and cost, are important when a method
or instrument is being selected for use in the
clinical laboratory. The total hands-on time
required to analyse a comparable number of
specimens by culture and by the LightCycler
PCR assay was similar, but a longer period was
required to obtain the results by culture (48–72 h)
compared with the LightCycler assay (2 h). Inclu-
ding the cost of equipment (based upon an
amortisation of 5 years and a test run of ten
patient-specimens ⁄day ⁄ 260 days ⁄year), the total
estimated costs and time (including pre-analytical
processing and analysis) required to complete the
analysis of a single sample were: CHF11 (7 Euro)
and c. 48 h for culture; CHF16 (10 Euro) and 1.5 h
for LightCycler PCR with boiling; and CHF41
(27 Euro) and 2.5 h for LightCycler PCR with the
MagNA Pure kit. However, these costs will
decrease with increasing numbers of samples.
The LightCycler PCR assay is relatively easy to
perform and may be adapted to small laborator-
ies. Thus, the ﬁnal choice for a laboratory (rt-PCR
vs. culture) will depend mainly on how urgently
the results are required.
The present study obtained more positive
results with the ampliﬁcation test than with
culture. In clinical microbiology, culture has,
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historically, been considered to be the standard
test. With the advent of nucleic acid ampliﬁcation
tests, this approach might now be considered
inappropriate in certain cases. After exclusion of
the possibility that nucleic acid ampliﬁcation test-
positive, culture-negative samples are false-posi-
tives (e.g., caused by laboratory contamination or
non-speciﬁc ampliﬁcation), it should be consid-
ered that culture might be hindered by the
presence of inhibitors in the sample. Thus, the
general statement that ‘a test cannot, by deﬁni-
tion, be more sensitive than the standard of
culture’ can be questioned. This has been debated
for Chlamydia trachomatis, and to a lesser extent,
for Neisseria gonorrhoeae infections [19–21]. In
order to improve the development of new diag-
nostic tests, it is imperative to revisit the standard
test concept, considering the advantages and
disadvantages of nucleic acid ampliﬁcation tests
for each aetiological agent and in relation to each
individual disease.
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